NCT04823312View on ClinicalTrials.gov

Evaluation of Medtronic DUO Extended Set

NAUnknownINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

March 18, 2021

Primary Completion Date

October 1, 2021

Study Completion Date

November 1, 2021

Conditions
Diabetes Mellitus, Type 1
Interventions
DEVICE

Experimental prospective single arm evaluating the Medtronic Duo Extended Set

Subjects will be using 4 Duo extended sets that will serve as an exploratory pilot study to assess the 7-day survival of the Duo Extended set.

Trial Locations (1)

30318

RECRUITING

Atlanta Diabetes Associates, Atlanta

Sponsors

Collaborators (1)

Medtronic
All Listed Sponsors
collaborator

Medtronic

INDUSTRY

lead

Atlanta Diabetes Associates

OTHER

NCT04823312 - Evaluation of Medtronic DUO Extended Set | Biotech Hunter | Biotech Hunter